Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

TERMINATED
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
Description

This is a multi-center, open-label study for eligible participants who were actively participating in the BPS-314d-MR-PAH-302 double-blind study (NCT01908699) at the time the study was concluded. This open-label extension (OLE) study will evaluate the safety, tolerability, and efficacy of long-term treatment with esuberaprost sodium tablets (Beraprost Sodium 314d Modified Release tablets).